PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 96 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $871,733 | +46.7% | 84,063 | +102.6% | 0.00% | +100.0% |
| Q2 2023 | $594,280 | +186.0% | 41,500 | +42.6% | 0.00% | 0.0% |
| Q1 2023 | $207,774 | -30.3% | 29,100 | -17.6% | 0.00% | 0.0% |
| Q2 2022 | $298,000 | -45.5% | 35,304 | -12.2% | 0.00% | -50.0% |
| Q1 2022 | $547,000 | -56.4% | 40,216 | -37.0% | 0.00% | -33.3% |
| Q4 2021 | $1,255,000 | +73.3% | 63,796 | +182.8% | 0.00% | +50.0% |
| Q3 2021 | $724,000 | -46.5% | 22,555 | -43.6% | 0.00% | -33.3% |
| Q2 2021 | $1,353,000 | -34.1% | 39,984 | -26.8% | 0.00% | -40.0% |
| Q1 2021 | $2,053,000 | – | 54,655 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $68,694,000 | 39.92% |
| Greenspring Associates, LLC | 360,939 | $11,990,000 | 15.57% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $193,587,000 | 14.91% |
| Abingworth LLP | 1,203,135 | $39,956,000 | 13.67% |
| Penn Mutual Asset Management | 86,940 | $2,888,000 | 2.55% |
| RA Capital Management | 3,825,008 | $127,067,000 | 1.78% |
| LUMINUS MANAGEMENT LLC | 126,903 | $4,216,000 | 0.98% |
| Pinz Capital Management, LP | 33,600 | $1,116,000 | 0.51% |
| Rhenman & Partners Asset Management AB | 175,000 | $5,814,000 | 0.47% |
| Summit Rock Advisors, LP | 34,350 | $1,141,000 | 0.40% |